Avalo Therapeutics Statistics
NASDAQ: AVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.58-0.01 (-0.07%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 13.58 0.00%
Avalo Therapeutics by the numbers
Avalo Therapeutics has a market capitalization of $728.3 million based on 53.63M shares outstanding. With trailing EPS of $-4.31, Avalo Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.4% below its 50-day average and 18.6% below its 200-day average.
Average daily trading volume is 935.17K shares, or about $12.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AVTX valuation vs. peer median
| Metric | AVTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $728.30M | $739.03M | -1% |
| Avg. volume | 935.17K | 907.80K | +3% |
Peer median across 8 companies: DSGN, COLL, GYRE, VSTM, APMD, WVE, ANNX, OLMA.
Valuation
- Market cap
- $728.30M
- EPS (TTM)
- $-4.31
- Shares outstanding
- 53.63M
Price and trading
- Previous close
- 13.59
- Open
- 13.43
- Day range
- 13.30 – 13.96
- 52-week range
- 12.51 – 24.27
- 52-week change
- +0.74%
- Beta
- —
- Volume
- 719.02K
- Average volume
- 935.17K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 728.30M
- Forward Pe
- -5.01
- Eps
- -4.31
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 24.27
- Week52 Low
- 12.51
- Avg Volume
- 935.17K
- Shares Outstanding
- 53.63M
- Ma50
- 17.96
- Ma200
- 16.68
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -44.05%
- Pct From52w Low
- 8.55%